Evidence map›Paper›PMID 33477850›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Costs of Point-of-Care Viral Load Testing for Adults and Children Living with HIV in Kenya.

Michelle Ann Bulterys, Patrick Oyaro, Evelyn Brown, Nashon Yongo, Enericah Karauki, James Wagude, Leonard Kingwara, Nancy Bowen, Susan Njogo, Anjuli D Wagner and 5 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. "Diagnostics (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Michelle Ann BulterysDepartments of Epidemiology and Global Health, University of Washington, Seattle, WA 98105, USA.ORCID 0000-0001-9403-5084
Patrick OyaroDepartments of Epidemiology and Global Health, University of Washington, Seattle, WA 98105, USA.
Evelyn BrownDepartment of HIV Research, University of Washington Kenya, Nairobi, Kenya.
Nashon YongoDepartment of HIV Research, University of Washington Kenya, Nairobi, Kenya.
Enericah KaraukiDepartment of HIV Research, University of Washington Kenya, Nairobi, Kenya.
James WagudeDepartment of Health, Siaya County, Kenya.ORCID 0000-0003-4793-9296
Leonard KingwaraNational HIV Reference Laboratory, National Public Health Laboratory, Nairobi, Kenya.ORCID 0000-0001-5382-8053
Nancy BowenNational HIV Reference Laboratory, National Public Health Laboratory, Nairobi, Kenya.
Susan NjogoNational AIDS and STI Control Programme, Ministry of Health, Nairobi 19361, Kenya.
Anjuli D WagnerDepartments of Epidemiology and Global Health, University of Washington, Seattle, WA 98105, USA.ORCID 0000-0002-5851-1220
Irene MukuiDepartments of Epidemiology and Global Health, University of Washington, Seattle, WA 98105, USA.
Frederick OluochNational HIV Reference Laboratory, National Public Health Laboratory, Nairobi, Kenya.
Lisa AbuogiDepartment of Pediatrics, University of Colorado, Denver, CO 80045, USA.
Rena PatelDepartments of Epidemiology and Global Health, University of Washington, Seattle, WA 98105, USA.ORCID 0000-0001-9893-5856
Monisha SharmaDepartments of Epidemiology and Global Health, University of Washington, Seattle, WA 98105, USA.ORCID 0000-0002-7599-1561
University of Washington · USUniversity of Nairobi · KEMinistry of Health · KENakuru County Council · KEUniversity of Colorado Denver · US

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Designing an Intervention to Increase Men's Linkage to Care and Prevention after HIV Self-Testing in UgandaK01MH115789 · NIMH · UNIVERSITY OF WASHINGTON · PI SHARMA, MONISHA · 2018 to 2022
$876k
Optimizing viral load suppression in Kenyan children on antiretroviral therapy (Opt4Kids)R34MH115769 · NIMH · UNIVERSITY OF WASHINGTON · PI ABUOGI, LISA LYNN, PATEL, RENA CHIMAN · 2018 to 2019
$698k
Optimizing viral suppression for pregnant and postpartum women living with HIV through HIV resistance testing (Opt4Mamasplus)R21AI145450 · NIAID · UNIVERSITY OF WASHINGTON · PI PATEL, RENA CHIMAN · 2019 to 2020
$453k
National Institute of Allergy and Infectious Diseases NIH R21AI145450NIAID NIH HHS R21 AI145450NIAID NIH HHS T32 AI007140NIMH NIH HHS K01 MH115789NIMH NIH HHS K01MH115789NIMH NIH HHS NIH R34MH115769NIMH NIH HHS R34 MH115769Thrasher Research Fund 15240University of Washington/Fred Hutch Center for AIDS Research NIH P30AI027757
6 · The paper itself

Abstract

backgroundThe number of people living with HIV (PLHIV) in need of treatment monitoring in low-and-middle-income countries is rapidly expanding, straining existing laboratory capacity. Point-of-care viral load (POC VL) testing can alleviate the burden on centralized laboratories and enable faster delivery of results, improving clinical outcomes. However, implementation costs are uncertain and will depend on clinic testing volume. We sought to estimate the costs of decentralized POC VL testing compared to centralized laboratory testing for adults and children receiving HIV care in Kenya.

methodsWe conducted microcosting to estimate the per-patient costs of POC VL testing compared to known costs of centralized laboratory testing. We completed time-and-motion observations and stakeholder interviews to assess personnel structures, staff time, equipment costs, and laboratory processes associated with POC VL administration. Capital costs were estimated using a 5 year lifespan and a 3% annual discount rate.

resultsWe estimated that POC VL testing cost USD $24.25 per test, assuming a clinic is conducting 100 VL tests per month. Test cartridge and laboratory equipment costs accounted for most of the cost (62% and 28%, respectively). Costs varied by number of VL tests conducted at the clinic, ranging from $54.93 to $18.12 per test assuming 20 to 500 VL tests per month, respectively. A VL test processed at a centralized laboratory was estimated to cost USD $25.65.

conclusionPOC VL testing for HIV treatment monitoring can be feasibly implemented in clinics within Kenya and costs declined with higher testing volumes. Our cost estimates are useful to policymakers in planning resource allocation and can inform cost-effectiveness analyses evaluating POC VL testing.

Indexed as

costingHIV careHIV managementpoint-of-care viral load testingviral load test

Identifiers

PMID33477850
PMCPMC7832863
OpenAlexW3124153440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.